rs3135506, APOA5

N. diseases: 26
Source: ALL
Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
Triglycerides measurement
CUI: C0202236
Disease: Triglycerides measurement
0.800 GeneticVariation GWASCAT Genetic analyses of diverse populations improves discovery for complex traits. 31217584 2019
Triglycerides measurement
CUI: C0202236
Disease: Triglycerides measurement
0.800 GeneticVariation GWASCAT A large electronic-health-record-based genome-wide study of serum lipids. 29507422 2018
Triglycerides measurement
CUI: C0202236
Disease: Triglycerides measurement
0.800 GeneticVariation GWASDB Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci. 23063622 2012
Triglycerides measurement
CUI: C0202236
Disease: Triglycerides measurement
0.800 GeneticVariation GWASDB Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. 19060911 2009
Serum total cholesterol measurement
CUI: C1445957
Disease: Serum total cholesterol measurement
0.700 GeneticVariation GWASCAT Genetic analyses of diverse populations improves discovery for complex traits. 31217584 2019
High density lipoprotein measurement
0.700 GeneticVariation GWASCAT Genetic analyses of diverse populations improves discovery for complex traits. 31217584 2019
Serum total cholesterol measurement
CUI: C1445957
Disease: Serum total cholesterol measurement
0.700 GeneticVariation GWASCAT A large electronic-health-record-based genome-wide study of serum lipids. 29507422 2018
High density lipoprotein measurement
0.700 GeneticVariation GWASCAT A large electronic-health-record-based genome-wide study of serum lipids. 29507422 2018
Serum total cholesterol measurement
CUI: C1445957
Disease: Serum total cholesterol measurement
0.700 GeneticVariation GWASCAT Genetics of blood lipids among ~300,000 multi-ethnic participants of the Million Veteran Program. 30275531 2018
HYPERTRIGLYCERIDEMIA, SUSCEPTIBILITY TO
0.700 SusceptibilityMutation CLINVAR
Metabolic Syndrome X
CUI: C0524620
Disease: Metabolic Syndrome X
0.070 GeneticVariation BEFREE In this study, we aimed to determine the association of single nucleotide polymorphisms including: rs662799, rs3135506 and rs2075291 in the apolipoprotein A-V (APOA5) gene in relation to MetS component like triglyceride and HDL-C level in Tehran Lipid and Glucose Study (TLGS). 26702748 2016
Metabolic Syndrome X
CUI: C0524620
Disease: Metabolic Syndrome X
0.070 GeneticVariation BEFREE Two common variants of ApoA5 (namely -1131T>C in the promoter region and c.56C>G in the coding region) with the risk of MetS were analyzed. 22905904 2012
Metabolic Syndrome X
CUI: C0524620
Disease: Metabolic Syndrome X
0.070 GeneticVariation BEFREE The minor allele of rs9939609 (FTO), rs7903146 (TCF7L2), C56G (APOA5), T1131C (APOA5), C482T (APOC3), C455T (APOC3) and 174G>C (IL6) were more prevalent in subjects with MetS, whereas the minor allele of Taq-1B (CETP) was less prevalent in subjects with the MetS. 21749608 2011
Metabolic Syndrome X
CUI: C0524620
Disease: Metabolic Syndrome X
0.070 GeneticVariation BEFREE Here we determined four haplotype-tagging polymorphisms (T-1131C, IVS3+G476A, T1259C, and C56G), and studied the distribution of the naturally occurring major haplotype profiles in MS. 19692219 2010
Metabolic Syndrome X
CUI: C0524620
Disease: Metabolic Syndrome X
0.070 GeneticVariation BEFREE APOA5 -1131T > C and S19W single nucleotide polymorphisms (SNP) have been consistently associated with plasma lipid concentration and metabolic syndrome (MetS), alone and in modulation by dietary factors. 19828688 2009
Metabolic Syndrome X
CUI: C0524620
Disease: Metabolic Syndrome X
0.070 GeneticVariation BEFREE Gender-modulated impact of apolipoprotein A5 gene (APOA5) -1131T>C and c.56C>G polymorphisms on lipids, dyslipidemia and metabolic syndrome in Turkish adults. 18601598 2008
Metabolic Syndrome X
CUI: C0524620
Disease: Metabolic Syndrome X
0.070 GeneticVariation BEFREE Furthermore, the data suggest a different mechanism of APOA5 impact on MetS in Caucasians, as variant c.56C>G (not analyzed in the Japanese study) and not -1131T>C, as in the Japanese subjects, was associated with MetS. 17768309 2007
Obesity
CUI: C0028754
Disease: Obesity
0.060 GeneticVariation BEFREE Association analysis of APOA5 rs662799 and rs3135506 polymorphisms with obesity in Moroccan patients. 26524954 2015
Obesity
CUI: C0028754
Disease: Obesity
0.060 GeneticVariation BEFREE The objective of this study was to analyze the interaction of a high fat diet with the APOA2 (rs3813627 and rs5082), APOA5 (rs662799 and rs3135506) and LEPR (rs8179183 and rs1137101) polymorphisms and its relationship with obesity and dyslipidemia in young subjects. 26365669 2015
Obesity
CUI: C0028754
Disease: Obesity
0.060 GeneticVariation BEFREE In current study two SNPs rs662799 risk allele G (P = 0.03) and rs3135506 risk allele C (P = 0.05) of APOA5 were found to be associated with significant higher risk of triglyceride levels, irrespective of age, sex, obesity, diabetes, hypertension and smoking. 24402875 2014
Obesity
CUI: C0028754
Disease: Obesity
0.060 GeneticVariation BEFREE In summary, we identified significant interactions for APOA5 S19W and LPL m107 for obesity in Caribbean Hispanics. 19629056 2010
Obesity
CUI: C0028754
Disease: Obesity
0.060 GeneticVariation BEFREE We found that: (i) genotypes, including those of APOA5 S19W, APOA5 -1131T > C, APOE, GCKR, TRIB1 and TBL2/MLXIPL, were significantly associated with severe HTG; (ii) odds ratios for these genetic variables were significant in both univariate and multivariate regression analyses, irrespective of the presence or absence of diabetes or obesity; (iii) a significant fraction-about one-quarter-of the explained variation in disease status was associated with these genotypes. 18596051 2008
Obesity
CUI: C0028754
Disease: Obesity
0.060 GeneticVariation BEFREE Specifically, we have examined the interaction between the APOA5-1131T>C and 56C>G (S19W) polymorphisms and the macronutrient intake (total fat, carbohydrate, and protein) in their relation to the body mass index (BMI) and obesity risk in 1,073 men and 1,207 women participating in the Framingham Offspring Study. 17211608 2007
Coronary Artery Disease
CUI: C1956346
Disease: Coronary Artery Disease
0.050 GeneticVariation BEFREE Mediation analysis yielded a mediation effect of p.S19W on risk of premature CAD through HDL-C (OR = 0.98, P = 0.040) and TG (OR = 0.98, P = 0.042), suggesting a causal relationship between p.S19W and premature CAD partially through its effects on HDL-C and TG levels. 30024021 2018
Coronary Artery Disease
CUI: C1956346
Disease: Coronary Artery Disease
0.050 GeneticVariation BEFREE The genetic variants of rs3135506 (G), rs10455872 (A) and rs3798220 (G) have low frequency in our population and reflected no association with CAD. 29309886 2018